Suchergebnisse - "KE CHANGWEN"

PubPharm (8)

1

SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis

enthalten in: Redox biology | 2023

von Liu, L. | Du, J. | Yang, S. | +12

2

Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants

enthalten in: Virology journal | 2022

von Liao, G. | Lau, H. | Liu, Z. | +32

3

Development of Receptor Binding Domain (RBD)-Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS-CoV-2 Delta and Other Variants

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2022

von Chen, R. | Zhang, X. | Yuan, Y. | +26

4

Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates

enthalten in: ACS nano | 2021

von Kang, Y. | Sun, C. | Zhuang, Z. | +18

5

A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract

enthalten in: Cellular & molecular immunology | 2020

von Hu, F. | Chen, F. | Ou, Z. | +19

6

Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2

enthalten in: Journal of virology | 2020

von Liu, Z. | Zheng, H. | Lin, H. | +18

7

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

enthalten in: Cell | 2020

von Dai, L. | Zheng, T. | Xu, K. | +18

8

Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids

enthalten in: Emerging infectious diseases | 2020

von Sun, J. | Xiao, J. | Sun, R. | +15

1
[1]